Perfectus Biomed Group, Now Part of NAMSA is a biotechnology and health care company based in the United Kingdom. Established in 2012, the company has garnered recognition for its accomplishments in providing comprehensive testing services in the medical and pharmaceutical sectors. Their expertise lies in tailoring antimicrobial assays, performing customised biofilm methodologies, and aiding clients in regulatory approval procedures. Additionally, they offer microbiological testing services across various industries including wound care, medical devices, pharmaceuticals, cosmetics, disinfectants, and dentistry. Perfectus Biomed Group has demonstrated a commitment to industry standards with accreditations from key regulatory bodies such as GLP, MHRA, ISO 9001, and ISO 17025. The company's growth and innovation have been acknowledged through prestigious awards such as the BioNow Technical Services Award and the High Sheriff’s Awards for Enterprise. Their last investment was a grant received on 03 September 2019 from the National Biofilms Innovation Centre. With a track record of excellence and a diverse range of services, Perfectus Biomed Group continues to be a leading player in the biotechnology and healthcare sectors, offering valuable solutions globally.
No recent news or press coverage available for Perfectus Biomed Group, Now Part of NAMSA.